What are the major opportunities in the Specific Antiviral Drugs For COVID 19 market? What are the strategies for the Specific Antiviral Drugs For COVID 19 market?

For detailed insights on the major opportunities and strategies in the Specific Antiviral Drugs For COVID 19 market, Read More

How does the Specific Antiviral Drugs For COVID 19 market relate to the overall economy and other similar markets?

For detailed insights on Specific Antiviral Drugs For COVID 19's relation to the overall economy and other similar markets, Read More

What are the key dynamics influencing the Specific Antiviral Drugs For COVID 19 market growth? SWOT analysis of the Specific Antiviral Drugs For COVID 19 market.

For detailed insights on the key dynamics influencing the Specific Antiviral Drugs For COVID 19 market growth and SWOT analysis of the Specific Antiviral Drugs For COVID 19 industry, Read More

Global Specific Antiviral Drugs For COVID 19 Market Report 2025

Item added to cart!

Published : December 2025

Pages : 200

Format : PDF

Delivery Time : 2-3 Business Days

Report Price : $4490.00 $3367.00

Purchase This Report Download Sample PDF

Purchase This Report

Specific Antiviral Drugs For COVID 19 Global Market Report 2025

Name: Specific Antiviral Drugs For COVID 19 Global Market Report 2025
Brand: The Business Research Company
Price: 4490.00 USD
Availability: InStock

By Type (Tablet, Injection), By Indication (Hospitalized Patients, Non-Hospitalized Patients, Preventive Treatment), By Drug Class (Nucleoside Analogues, Protease Inhibitors, Ribonucleic Acid Polymerase Inhibitors, Entry Inhibitors, Monoclonal Antibodies), By Route Of Administration (Oral, Intravenous, Subcutaneous, Inhalation), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Other Distribution Channels) - Market Size, Trends, And Global Forecast 2025-2034

Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report’s Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.

What Is Covered Under Specific Antiviral Drugs For COVID 19 Market?

Specific antiviral drugs for COVID-19 are medications designed to directly target and inhibit the replication or function of the SARS-CoV-2 virus, which causes COVID-19. These drugs help reduce the severity and duration of the infection by interfering with viral processes such as entry, replication, or assembly.

The main types of specific antiviral drugs for COVID-19 come in tablet and injection forms. Tablets are solid pharmaceutical dosage forms that contain a precise amount of active medicinal ingredient(s) along with excipients, compressed into a small, usually flat or oval shape. These antiviral drugs are indicated for use in hospitalized patients, non-hospitalized patients, and for preventive treatment. The drug classes include nucleoside analogues, Protease Inhibitors, RNA polymerase inhibitors, entry inhibitors, and monoclonal antibodies, and they are administered via various routes such as oral, intravenous, subcutaneous, and inhalation. These medications are distributed through multiple channels, including hospital pharmacies, retail pharmacies, and other outlets.

Specific Antiviral Drugs For COVID 19 Market Size and growth rate 2025 to 2029: Graph

What Is The Specific Antiviral Drugs For COVID 19 Market Size 2025 And Growth Rate?

The specific antiviral drugs for covid 19 market size has grown rapidly in recent years. It will grow from $13 billion in 2024 to $15.23 billion in 2025 at a compound annual growth rate (CAGR) of 17.1%. The growth in the historic period can be attributed to rising hospitalization due to severe cases, increasing government funding for antiviral research, increasing demand for targeted therapeutics over generic treatments, rising awareness about early antiviral intervention, and increasing collaborations among pharmaceutical companies.

What Is The Specific Antiviral Drugs For COVID 19 Market Growth Forecast?

The specific antiviral drugs for covid 19 market size is expected to see rapid growth in the next few years. It will grow to $28.43 billion in 2029 at a compound annual growth rate (CAGR) of 16.9%. The growth in the forecast period can be attributed to increasing focus on pandemic preparedness, increasing number of clinical trials, growing demand for effective COVID-19 treatment options, increasing prevalence of COVID-19 variants, and growing acceptance of oral antiviral therapies. Major trends in the forecast period include innovation in broad-spectrum antiviral formulations, integration of artificial intelligence in drug discovery, advancement in personalized antiviral therapies, innovation in combination therapy approaches, and integration of genomic data to target viral mutations.

Book your 30 minutes free consultation with our research experts

How Is The Specific Antiviral Drugs For COVID 19 Market Segmented?

The specific antiviral drugs for covid 19 market covered in this report is segmented –

1) By Type: Tablet, Injection

2) By Indication: Hospitalized Patients, Non-Hospitalized Patients, Preventive Treatment

3) By Drug Class: Nucleoside Analogues, Protease Inhibitors, Ribonucleic Acid Polymerase Inhibitors, Entry Inhibitors, Monoclonal Antibodies

4) By Route Of Administration: Oral, Intravenous, Subcutaneous, Inhalation

5) By Distribution Channel: Hospital Pharmacies, Retail Pharmacies, Other Distribution Channels

Subsegments

1) By Tablet: Oral Antiviral Tablets, Combination Antiviral Tablets, Extended-Release Tablets

2) By Injection: Intravenous (IV) Antiviral Injections, Intramuscular (IM) Antiviral Injections, Subcutaneous Antiviral Injections

What Is Driving The Specific Antiviral Drugs For COVID 19 Market? Rise In COVID-19 Cases The Growth Of The Market Due To Increasing Demand For Antiviral Treatments

The rising number of COVID-19 cases is expected to propel the growth of the specific antiviral drugs for the COVID-19 market going forward. COVID-19 cases refer to individuals who tested positive for the SARS-CoV-2 virus, which causes COVID-19. The rising number of COVID-19 cases is due to the emergence of new variants that spread more easily and can partially evade immunity from vaccines or past infections. Specific antiviral drugs for COVID-19 help reduce the severity and duration of the illness, improving patient outcomes and lowering the overall burden of COVID-19 cases. For instance, in May 2023, according to the Centers for Disease Control and Prevention, a US-based government agency, on average, COVID-19 deaths that included additional causes of death had 4.5 contributing conditions listed in 2022, compared to 4.2 in 2021. Therefore, the rising number of COVID-19 cases drives the growth of the specific antiviral drugs for the COVID-19 market.

Who Are The Major Players In The Global Specific Antiviral Drugs For COVID 19 Market?

Major companies operating in the specific antiviral drugs for covid 19 market are Pfizer Inc., Johnson and Johnson, Roche Holding AG, Merck And Co. Inc., Novartis AG, GSK plc, Eli Lilly and Company, Gilead Sciences Inc., Regeneron Pharmaceuticals Inc, Hetero Drugs Limited, Sun Pharmaceutical Industries Limited, Shionogi and Co. Ltd., Cipla Limited, Beximco Pharmaceuticals Limited, BioCryst Pharmaceuticals Inc., Atea Pharmaceuticals Inc., Enanta Pharmaceuticals Inc., RedHill Biopharma Ltd., Aligos Therapeutics Inc., Synairgen plc

What Are The Key Trends Of The Global Specific Antiviral Drugs For COVID 19 Market? Oral Antiviral Innovations Enhance COVID-19 Treatment Accessibility And Effectiveness

Major companies operating in the specific antiviral drugs for the COVID-19 market are focusing on developing innovative therapies, such as oral antiviral therapies, to enhance treatment accessibility and effectiveness. Oral antiviral therapies are medications taken by mouth to inhibit the replication of viruses like COVID-19, offering a convenient and effective treatment option. For instance, in January 2022, Lupin Limited, an India-based pharmaceutical company, launched the antiviral drug Molnupiravir under the brand name Molnulup to treat high-risk adult patients with COVID-19. This oral medication is intended for adults with mild to moderate COVID-19 who are at risk of developing severe illness. Molnupiravir works by inhibiting the replication of the SARS-CoV-2 virus, thereby helping to lower the viral load and reduce the severity of the disease. It is most effective when started within five days of symptom onset and is especially beneficial for individuals with comorbid conditions such as obesity, advanced age, diabetes, or cardiovascular disease.

Need data on a specific region in this market?

Request Regional Data

What Are Latest Mergers And Acquisitions In The Specific Antiviral Drugs For COVID 19 Market? GSK And Curevac Collaborate To Develop Innovative Mrna Vaccines For Influenza And COVID-19

In July 2024, GSK plc, a UK-based pharmaceutical company, collaborated with CureVac to develop and commercialize next-generation mRNA vaccines for COVID-19 and influenza. This collaboration aims to develop and commercialize innovative mRNA vaccines for influenza and COVID-19 to improve global public health outcomes. CureVac N.V. is a Germany-based company that develops therapies based on messenger RNA (mRNA) technology.

What Is The Regional Outlook For The Global Specific Antiviral Drugs For COVID 19 Market?

North America was the largest region in the specific antiviral drugs for COVID 19 market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the specific antiviral drugs for covid 19 market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the specific antiviral drugs for covid 19 market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

What Defines the Specific Antiviral Drugs For COVID 19 Market?

The specific antiviral drugs for COVID-19 market consists of sales of host-directed antivirals, immunomodulators, fusion inhibitors, helicase inhibitors, and tmprss2 inhibitors. Values in this market are ‘factory gate’ values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

How is Market Value Defined and Measured?

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

What is the Market Assessment and Strategic Outlook for the Specific Antiviral Drugs For COVID 19 Industry?

The specific antiviral drugs for COVID-19 market research report is one of a series of new reports from The Business Research Company that cover specific antiviral drugs for COVID-19 market statistics, including the specific antiviral drugs for COVID-19 industry's global market size, regional shares, competitors with the specific antiviral drugs for COVID-19 market share, detailed specific antiviral drugs for COVID-19 market segments, market trends and opportunities, and any further data you may need to thrive in the specific antiviral drugs for COVID-19 market. This specific antiviral drugs for COVID-19 market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenarios of the industry.

Author : Abhilash Pyata

Specific Antiviral Drugs For COVID 19 Market Report Forecast Analysis

Report Attribute	Details
Market Size Value In 2025	$15.23 billion
Revenue Forecast In 2034	$28.43 billion
Growth Rate	CAGR of 16.9% from 2025 to 2034
Base Year For Estimation	2024
Actual Estimates/Historical Data	2019-2024
Forecast Period	2025 - 2029 - 2034
Market Representation	Revenue in USD Billion and CAGR from 2025 to 2034
Segments Covered	The specific antiviral drugs for covid 19 market covered in this report is segmented – 1) By Type: Tablet, Injection 2) By Indication: Hospitalized Patients, Non-Hospitalized Patients, Preventive Treatment 3) By Drug Class: Nucleoside Analogues, Protease Inhibitors, Ribonucleic Acid Polymerase Inhibitors, Entry Inhibitors, Monoclonal Antibodies 4) By Route Of Administration: Oral, Intravenous, Subcutaneous, Inhalation 5) By Distribution Channel: Hospital Pharmacies, Retail Pharmacies, Other Distribution Channels Subsegments 1) By Tablet: Oral Antiviral Tablets, Combination Antiviral Tablets, Extended-Release Tablets 2) By Injection: Intravenous (IV) Antiviral Injections, Intramuscular (IM) Antiviral Injections, Subcutaneous Antiviral Injections
Regional Scope	Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa
Country Scope	The countries covered in the report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain. Additional countries that can be covered in the report are Bangladesh, Thailand, Vietnam, Malaysia, Singapore, Philippines, Hong Kong, New Zealand, Mexico, Chile, Argentina, Colombia, Peru, Austria, Belgium, Denmark, Finland, Ireland, Netherlands, Norway, Portugal, Sweden, Switzerland, Czech Republic, Poland, Romania, Ukraine, Saudi Arabia, Israel, Iran, Turkey, UAE, Egypt, Nigeria, South Africa.
Key Companies Profiled	Pfizer Inc., Johnson and Johnson, Roche Holding AG, Merck And Co. Inc., Novartis AG, GSK plc, Eli Lilly and Company, Gilead Sciences Inc., Regeneron Pharmaceuticals Inc, Hetero Drugs Limited, Sun Pharmaceutical Industries Limited, Shionogi and Co. Ltd., Cipla Limited, Beximco Pharmaceuticals Limited, BioCryst Pharmaceuticals Inc., Atea Pharmaceuticals Inc., Enanta Pharmaceuticals Inc., RedHill Biopharma Ltd., Aligos Therapeutics Inc., Synairgen plc
Customization Scope	Request for Sample
Pricing And Purchase Options	Explore Purchase Options

1. Executive Summary

2. Specific Antiviral Drugs For COVID 19 Market Characteristics

3. Specific Antiviral Drugs For COVID 19 Market Trends And Strategies

4. Specific Antiviral Drugs For COVID 19 Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, And Covid And Recovery On The Market

5. Global Specific Antiviral Drugs For COVID 19 Growth Analysis And Strategic Analysis Framework

5.1. Global Specific Antiviral Drugs For COVID 19 PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)

5.2. Analysis Of End Use Industries

5.3. Global Specific Antiviral Drugs For COVID 19 Market Growth Rate Analysis

5.4. Global Specific Antiviral Drugs For COVID 19 Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)

5.5. Global Specific Antiviral Drugs For COVID 19 Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)

5.6. Global Specific Antiviral Drugs For COVID 19 Total Addressable Market (TAM)

6. Specific Antiviral Drugs For COVID 19 Market Segmentation

6.1. Global Specific Antiviral Drugs For COVID 19 Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Tablet

Injection

6.2. Global Specific Antiviral Drugs For COVID 19 Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Hospitalized Patients

Non-Hospitalized Patients

Preventive Treatment

6.3. Global Specific Antiviral Drugs For COVID 19 Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Nucleoside Analogues

Protease Inhibitors

Ribonucleic Acid Polymerase Inhibitors

Entry Inhibitors

Monoclonal Antibodies

6.4. Global Specific Antiviral Drugs For COVID 19 Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Oral

Intravenous

Subcutaneous

Inhalation

6.5. Global Specific Antiviral Drugs For COVID 19 Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Hospital Pharmacies

Retail Pharmacies

Other Distribution Channels

6.6. Global Specific Antiviral Drugs For COVID 19 Market, Sub-Segmentation Of Tablet, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Oral Antiviral Tablets

Combination Antiviral Tablets

Extended-Release Tablets

6.7. Global Specific Antiviral Drugs For COVID 19 Market, Sub-Segmentation Of Injection, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Intravenous (IV) Antiviral Injections

Intramuscular (IM) Antiviral Injections

Subcutaneous Antiviral Injections

7. Specific Antiviral Drugs For COVID 19 Market Regional And Country Analysis

7.1. Global Specific Antiviral Drugs For COVID 19 Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

7.2. Global Specific Antiviral Drugs For COVID 19 Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Specific Antiviral Drugs For COVID 19 Market

8.1. Asia-Pacific Specific Antiviral Drugs For COVID 19 Market Overview

Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

8.2. Asia-Pacific Specific Antiviral Drugs For COVID 19 Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8.3. Asia-Pacific Specific Antiviral Drugs For COVID 19 Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8.4. Asia-Pacific Specific Antiviral Drugs For COVID 19 Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Specific Antiviral Drugs For COVID 19 Market

9.1. China Specific Antiviral Drugs For COVID 19 Market Overview

9.2. China Specific Antiviral Drugs For COVID 19 Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

9.3. China Specific Antiviral Drugs For COVID 19 Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

9.4. China Specific Antiviral Drugs For COVID 19 Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Specific Antiviral Drugs For COVID 19 Market

10.1. India Specific Antiviral Drugs For COVID 19 Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

10.2. India Specific Antiviral Drugs For COVID 19 Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

10.3. India Specific Antiviral Drugs For COVID 19 Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Specific Antiviral Drugs For COVID 19 Market

11.1. Japan Specific Antiviral Drugs For COVID 19 Market Overview

11.2. Japan Specific Antiviral Drugs For COVID 19 Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11.3. Japan Specific Antiviral Drugs For COVID 19 Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11.4. Japan Specific Antiviral Drugs For COVID 19 Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Specific Antiviral Drugs For COVID 19 Market

12.1. Australia Specific Antiviral Drugs For COVID 19 Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12.2. Australia Specific Antiviral Drugs For COVID 19 Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12.3. Australia Specific Antiviral Drugs For COVID 19 Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Specific Antiviral Drugs For COVID 19 Market

13.1. Indonesia Specific Antiviral Drugs For COVID 19 Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13.2. Indonesia Specific Antiviral Drugs For COVID 19 Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13.3. Indonesia Specific Antiviral Drugs For COVID 19 Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Specific Antiviral Drugs For COVID 19 Market

14.1. South Korea Specific Antiviral Drugs For COVID 19 Market Overview

14.2. South Korea Specific Antiviral Drugs For COVID 19 Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14.3. South Korea Specific Antiviral Drugs For COVID 19 Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14.4. South Korea Specific Antiviral Drugs For COVID 19 Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe Specific Antiviral Drugs For COVID 19 Market

15.1. Western Europe Specific Antiviral Drugs For COVID 19 Market Overview

15.2. Western Europe Specific Antiviral Drugs For COVID 19 Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15.3. Western Europe Specific Antiviral Drugs For COVID 19 Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15.4. Western Europe Specific Antiviral Drugs For COVID 19 Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK Specific Antiviral Drugs For COVID 19 Market

16.1. UK Specific Antiviral Drugs For COVID 19 Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16.2. UK Specific Antiviral Drugs For COVID 19 Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16.3. UK Specific Antiviral Drugs For COVID 19 Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany Specific Antiviral Drugs For COVID 19 Market

17.1. Germany Specific Antiviral Drugs For COVID 19 Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17.2. Germany Specific Antiviral Drugs For COVID 19 Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17.3. Germany Specific Antiviral Drugs For COVID 19 Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France Specific Antiviral Drugs For COVID 19 Market

18.1. France Specific Antiviral Drugs For COVID 19 Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18.2. France Specific Antiviral Drugs For COVID 19 Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18.3. France Specific Antiviral Drugs For COVID 19 Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy Specific Antiviral Drugs For COVID 19 Market

19.1. Italy Specific Antiviral Drugs For COVID 19 Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19.2. Italy Specific Antiviral Drugs For COVID 19 Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19.3. Italy Specific Antiviral Drugs For COVID 19 Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain Specific Antiviral Drugs For COVID 19 Market

20.1. Spain Specific Antiviral Drugs For COVID 19 Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20.2. Spain Specific Antiviral Drugs For COVID 19 Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20.3. Spain Specific Antiviral Drugs For COVID 19 Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Specific Antiviral Drugs For COVID 19 Market

21.1. Eastern Europe Specific Antiviral Drugs For COVID 19 Market Overview

21.2. Eastern Europe Specific Antiviral Drugs For COVID 19 Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21.3. Eastern Europe Specific Antiviral Drugs For COVID 19 Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21.4. Eastern Europe Specific Antiviral Drugs For COVID 19 Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia Specific Antiviral Drugs For COVID 19 Market

22.1. Russia Specific Antiviral Drugs For COVID 19 Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22.2. Russia Specific Antiviral Drugs For COVID 19 Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22.3. Russia Specific Antiviral Drugs For COVID 19 Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America Specific Antiviral Drugs For COVID 19 Market

23.1. North America Specific Antiviral Drugs For COVID 19 Market Overview

23.2. North America Specific Antiviral Drugs For COVID 19 Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23.3. North America Specific Antiviral Drugs For COVID 19 Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23.4. North America Specific Antiviral Drugs For COVID 19 Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA Specific Antiviral Drugs For COVID 19 Market

24.1. USA Specific Antiviral Drugs For COVID 19 Market Overview

24.2. USA Specific Antiviral Drugs For COVID 19 Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24.3. USA Specific Antiviral Drugs For COVID 19 Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24.4. USA Specific Antiviral Drugs For COVID 19 Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada Specific Antiviral Drugs For COVID 19 Market

25.1. Canada Specific Antiviral Drugs For COVID 19 Market Overview

25.2. Canada Specific Antiviral Drugs For COVID 19 Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25.3. Canada Specific Antiviral Drugs For COVID 19 Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25.4. Canada Specific Antiviral Drugs For COVID 19 Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America Specific Antiviral Drugs For COVID 19 Market

26.1. South America Specific Antiviral Drugs For COVID 19 Market Overview

26.2. South America Specific Antiviral Drugs For COVID 19 Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26.3. South America Specific Antiviral Drugs For COVID 19 Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26.4. South America Specific Antiviral Drugs For COVID 19 Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil Specific Antiviral Drugs For COVID 19 Market

27.1. Brazil Specific Antiviral Drugs For COVID 19 Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27.2. Brazil Specific Antiviral Drugs For COVID 19 Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27.3. Brazil Specific Antiviral Drugs For COVID 19 Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East Specific Antiviral Drugs For COVID 19 Market

28.1. Middle East Specific Antiviral Drugs For COVID 19 Market Overview

28.2. Middle East Specific Antiviral Drugs For COVID 19 Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28.3. Middle East Specific Antiviral Drugs For COVID 19 Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28.4. Middle East Specific Antiviral Drugs For COVID 19 Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa Specific Antiviral Drugs For COVID 19 Market

29.1. Africa Specific Antiviral Drugs For COVID 19 Market Overview

29.2. Africa Specific Antiviral Drugs For COVID 19 Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29.3. Africa Specific Antiviral Drugs For COVID 19 Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29.4. Africa Specific Antiviral Drugs For COVID 19 Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Specific Antiviral Drugs For COVID 19 Market Competitive Landscape And Company Profiles

30.1. Specific Antiviral Drugs For COVID 19 Market Competitive Landscape

30.2. Specific Antiviral Drugs For COVID 19 Market Company Profiles

30.2.1. Pfizer Inc. Overview, Products and Services, Strategy and Financial Analysis

30.2.2. Johnson and Johnson Overview, Products and Services, Strategy and Financial Analysis

30.2.3. Roche Holding AG Overview, Products and Services, Strategy and Financial Analysis

30.2.4. Merck And Co. Inc. Overview, Products and Services, Strategy and Financial Analysis

30.2.5. Novartis AG Overview, Products and Services, Strategy and Financial Analysis

31. Specific Antiviral Drugs For COVID 19 Market Other Major And Innovative Companies

31.1. GSK plc

31.2. Eli Lilly and Company

31.3. Gilead Sciences Inc.

31.4. Regeneron Pharmaceuticals Inc

31.5. Hetero Drugs Limited

31.6. Sun Pharmaceutical Industries Limited

31.7. Shionogi and Co. Ltd.

31.8. Cipla Limited

31.9. Beximco Pharmaceuticals Limited

31.10. BioCryst Pharmaceuticals Inc.

31.11. Atea Pharmaceuticals Inc.

31.12. Enanta Pharmaceuticals Inc.

31.13. RedHill Biopharma Ltd.

31.14. Aligos Therapeutics Inc.

31.15. Synairgen plc

32. Global Specific Antiviral Drugs For COVID 19 Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Specific Antiviral Drugs For COVID 19 Market

34. Recent Developments In The Specific Antiviral Drugs For COVID 19 Market

35. Specific Antiviral Drugs For COVID 19 Market High Potential Countries, Segments and Strategies

35.1 Specific Antiviral Drugs For COVID 19 Market In 2029 - Countries Offering Most New Opportunities

35.2 Specific Antiviral Drugs For COVID 19 Market In 2029 - Segments Offering Most New Opportunities

35.3 Specific Antiviral Drugs For COVID 19 Market In 2029 - Growth Strategies

35.3.1 Market Trend Based Strategies

35.3.2 Competitor Strategies

36. Appendix

36.1. Abbreviations

36.2. Currencies

36.3. Historic And Forecast Inflation Rates

36.4. Research Inquiries

36.5. The Business Research Company

36.6. Copyright And Disclaimer

List Of Tables

Table 1: Global Historic Market Growth, 2019-2024, $ Billion

Table 2: Global Forecast Market Growth, 2024-2029F, 2034F, $ Billion

Table 3: Global Specific Antiviral Drugs For COVID 19 Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 4: Global Specific Antiviral Drugs For COVID 19 Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 5: Global Specific Antiviral Drugs For COVID 19 Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 6: Global Specific Antiviral Drugs For COVID 19 Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 7: Global Specific Antiviral Drugs For COVID 19 Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 8: Global Specific Antiviral Drugs For COVID 19 Market, Sub-Segmentation Of Tablet, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 9: Global Specific Antiviral Drugs For COVID 19 Market, Sub-Segmentation Of Injection, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 10: Global Specific Antiviral Drugs For COVID 19 Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 11: Global Specific Antiviral Drugs For COVID 19 Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 12: Asia-Pacific, Specific Antiviral Drugs For COVID 19 Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 13: Asia-Pacific, Specific Antiviral Drugs For COVID 19 Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 14: Asia-Pacific, Specific Antiviral Drugs For COVID 19 Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 15: China, Specific Antiviral Drugs For COVID 19 Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 16: China, Specific Antiviral Drugs For COVID 19 Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 17: China, Specific Antiviral Drugs For COVID 19 Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 18: India, Specific Antiviral Drugs For COVID 19 Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 19: India, Specific Antiviral Drugs For COVID 19 Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 20: India, Specific Antiviral Drugs For COVID 19 Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 21: Japan, Specific Antiviral Drugs For COVID 19 Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 22: Japan, Specific Antiviral Drugs For COVID 19 Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 23: Japan, Specific Antiviral Drugs For COVID 19 Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 24: Australia, Specific Antiviral Drugs For COVID 19 Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 25: Australia, Specific Antiviral Drugs For COVID 19 Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 26: Australia, Specific Antiviral Drugs For COVID 19 Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 27: Indonesia, Specific Antiviral Drugs For COVID 19 Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 28: Indonesia, Specific Antiviral Drugs For COVID 19 Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 29: Indonesia, Specific Antiviral Drugs For COVID 19 Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 30: South Korea, Specific Antiviral Drugs For COVID 19 Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 31: South Korea, Specific Antiviral Drugs For COVID 19 Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 32: South Korea, Specific Antiviral Drugs For COVID 19 Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 33: Western Europe, Specific Antiviral Drugs For COVID 19 Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 34: Western Europe, Specific Antiviral Drugs For COVID 19 Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 35: Western Europe, Specific Antiviral Drugs For COVID 19 Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 36: UK, Specific Antiviral Drugs For COVID 19 Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 37: UK, Specific Antiviral Drugs For COVID 19 Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 38: UK, Specific Antiviral Drugs For COVID 19 Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 39: Germany, Specific Antiviral Drugs For COVID 19 Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 40: Germany, Specific Antiviral Drugs For COVID 19 Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 41: Germany, Specific Antiviral Drugs For COVID 19 Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 42: France, Specific Antiviral Drugs For COVID 19 Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 43: France, Specific Antiviral Drugs For COVID 19 Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 44: France, Specific Antiviral Drugs For COVID 19 Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 45: Italy, Specific Antiviral Drugs For COVID 19 Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 46: Italy, Specific Antiviral Drugs For COVID 19 Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 47: Italy, Specific Antiviral Drugs For COVID 19 Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 48: Spain, Specific Antiviral Drugs For COVID 19 Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 49: Spain, Specific Antiviral Drugs For COVID 19 Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 50: Spain, Specific Antiviral Drugs For COVID 19 Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 51: Eastern Europe, Specific Antiviral Drugs For COVID 19 Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 52: Eastern Europe, Specific Antiviral Drugs For COVID 19 Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 53: Eastern Europe, Specific Antiviral Drugs For COVID 19 Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 54: Russia, Specific Antiviral Drugs For COVID 19 Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 55: Russia, Specific Antiviral Drugs For COVID 19 Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 56: Russia, Specific Antiviral Drugs For COVID 19 Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 57: North America, Specific Antiviral Drugs For COVID 19 Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 58: North America, Specific Antiviral Drugs For COVID 19 Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 59: North America, Specific Antiviral Drugs For COVID 19 Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 60: USA, Specific Antiviral Drugs For COVID 19 Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 61: USA, Specific Antiviral Drugs For COVID 19 Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 62: USA, Specific Antiviral Drugs For COVID 19 Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 63: Canada, Specific Antiviral Drugs For COVID 19 Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 64: Canada, Specific Antiviral Drugs For COVID 19 Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 65: Canada, Specific Antiviral Drugs For COVID 19 Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 66: South America, Specific Antiviral Drugs For COVID 19 Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 67: South America, Specific Antiviral Drugs For COVID 19 Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 68: South America, Specific Antiviral Drugs For COVID 19 Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 69: Brazil, Specific Antiviral Drugs For COVID 19 Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 70: Brazil, Specific Antiviral Drugs For COVID 19 Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 71: Brazil, Specific Antiviral Drugs For COVID 19 Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 72: Middle East, Specific Antiviral Drugs For COVID 19 Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 73: Middle East, Specific Antiviral Drugs For COVID 19 Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 74: Middle East, Specific Antiviral Drugs For COVID 19 Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 75: Africa, Specific Antiviral Drugs For COVID 19 Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 76: Africa, Specific Antiviral Drugs For COVID 19 Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 77: Africa, Specific Antiviral Drugs For COVID 19 Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 78: Pfizer Inc. Financial Performance

Table 79: Johnson and Johnson Financial Performance

Table 80: Roche Holding AG Financial Performance

Table 81: Merck And Co. Inc. Financial Performance

Table 82: Novartis AG Financial Performance

List Of Figures

Figure 1: Global Historic Market Growth, 2019-2024, $ Billion

Figure 2: Global Forecast Market Growth, 2024-2029F, 2034F, $ Billion

Figure 3: Global Specific Antiviral Drugs For COVID 19 Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 4: Global Specific Antiviral Drugs For COVID 19 Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 5: Global Specific Antiviral Drugs For COVID 19 Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 6: Global Specific Antiviral Drugs For COVID 19 Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 7: Global Specific Antiviral Drugs For COVID 19 Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 8: Global Specific Antiviral Drugs For COVID 19 Market, Sub-Segmentation Of Tablet, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 9: Global Specific Antiviral Drugs For COVID 19 Market, Sub-Segmentation Of Injection, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 10: Global Specific Antiviral Drugs For COVID 19 Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 11: Global Specific Antiviral Drugs For COVID 19 Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 12: Asia-Pacific, Specific Antiviral Drugs For COVID 19 Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 13: Asia-Pacific, Specific Antiviral Drugs For COVID 19 Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 14: Asia-Pacific, Specific Antiviral Drugs For COVID 19 Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 15: China, Specific Antiviral Drugs For COVID 19 Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 16: China, Specific Antiviral Drugs For COVID 19 Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 17: China, Specific Antiviral Drugs For COVID 19 Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 18: India, Specific Antiviral Drugs For COVID 19 Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 19: India, Specific Antiviral Drugs For COVID 19 Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 20: India, Specific Antiviral Drugs For COVID 19 Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 21: Japan, Specific Antiviral Drugs For COVID 19 Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 22: Japan, Specific Antiviral Drugs For COVID 19 Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 23: Japan, Specific Antiviral Drugs For COVID 19 Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 24: Australia, Specific Antiviral Drugs For COVID 19 Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 25: Australia, Specific Antiviral Drugs For COVID 19 Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 26: Australia, Specific Antiviral Drugs For COVID 19 Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 27: Indonesia, Specific Antiviral Drugs For COVID 19 Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 28: Indonesia, Specific Antiviral Drugs For COVID 19 Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 29: Indonesia, Specific Antiviral Drugs For COVID 19 Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 30: South Korea, Specific Antiviral Drugs For COVID 19 Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 31: South Korea, Specific Antiviral Drugs For COVID 19 Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 32: South Korea, Specific Antiviral Drugs For COVID 19 Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 33: Western Europe, Specific Antiviral Drugs For COVID 19 Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 34: Western Europe, Specific Antiviral Drugs For COVID 19 Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 35: Western Europe, Specific Antiviral Drugs For COVID 19 Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 36: UK, Specific Antiviral Drugs For COVID 19 Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 37: UK, Specific Antiviral Drugs For COVID 19 Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 38: UK, Specific Antiviral Drugs For COVID 19 Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 39: Germany, Specific Antiviral Drugs For COVID 19 Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 40: Germany, Specific Antiviral Drugs For COVID 19 Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 41: Germany, Specific Antiviral Drugs For COVID 19 Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 42: France, Specific Antiviral Drugs For COVID 19 Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 43: France, Specific Antiviral Drugs For COVID 19 Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 44: France, Specific Antiviral Drugs For COVID 19 Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 45: Italy, Specific Antiviral Drugs For COVID 19 Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 46: Italy, Specific Antiviral Drugs For COVID 19 Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 47: Italy, Specific Antiviral Drugs For COVID 19 Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 48: Spain, Specific Antiviral Drugs For COVID 19 Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 49: Spain, Specific Antiviral Drugs For COVID 19 Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 50: Spain, Specific Antiviral Drugs For COVID 19 Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 51: Eastern Europe, Specific Antiviral Drugs For COVID 19 Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 52: Eastern Europe, Specific Antiviral Drugs For COVID 19 Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 53: Eastern Europe, Specific Antiviral Drugs For COVID 19 Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 54: Russia, Specific Antiviral Drugs For COVID 19 Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 55: Russia, Specific Antiviral Drugs For COVID 19 Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 56: Russia, Specific Antiviral Drugs For COVID 19 Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 57: North America, Specific Antiviral Drugs For COVID 19 Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 58: North America, Specific Antiviral Drugs For COVID 19 Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 59: North America, Specific Antiviral Drugs For COVID 19 Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 60: USA, Specific Antiviral Drugs For COVID 19 Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 61: USA, Specific Antiviral Drugs For COVID 19 Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 62: USA, Specific Antiviral Drugs For COVID 19 Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 63: Canada, Specific Antiviral Drugs For COVID 19 Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 64: Canada, Specific Antiviral Drugs For COVID 19 Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 65: Canada, Specific Antiviral Drugs For COVID 19 Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 66: South America, Specific Antiviral Drugs For COVID 19 Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 67: South America, Specific Antiviral Drugs For COVID 19 Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 68: South America, Specific Antiviral Drugs For COVID 19 Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 69: Brazil, Specific Antiviral Drugs For COVID 19 Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 70: Brazil, Specific Antiviral Drugs For COVID 19 Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 71: Brazil, Specific Antiviral Drugs For COVID 19 Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 72: Middle East, Specific Antiviral Drugs For COVID 19 Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 73: Middle East, Specific Antiviral Drugs For COVID 19 Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 74: Middle East, Specific Antiviral Drugs For COVID 19 Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 75: Africa, Specific Antiviral Drugs For COVID 19 Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 76: Africa, Specific Antiviral Drugs For COVID 19 Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 77: Africa, Specific Antiviral Drugs For COVID 19 Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 78: Pfizer Inc. Financial Performance

Figure 79: Johnson and Johnson Financial Performance

Figure 80: Roche Holding AG Financial Performance

Figure 81: Merck And Co. Inc. Financial Performance

Figure 82: Novartis AG Financial Performance

Advanced Therapy Medicinal Products Industry Poised for Rapid Expansion, Projected to Hit $104.43 Billion by 2029

Global Insights: Androgen Deprivation Therapy Market Expected to Surpass $10.49 Billion by 2029

2025 Anti-CD20 Monoclonal Antibodies Market Outlook: Opportunities, Growth Trends, and Strategic Analysis

Future Projections: Anti-D Immunoglobulin Market to Reach $3.34 Billion by 2029 at 6.6% CAGR

Discover key trends and market dynamics in the Mycobacterium Tuberculosis Market with 2025 insights from The Business Research Company.

Discover key trends and market dynamics in the Smoking Cessation & Nicotine De-addiction Products Market with 2025 insights from The Business Research Company.

Discover key trends and market dynamics in the MSI-H and DMMR Market with 2025 insights from The Business Research Company.

Uncover TBRC’s strategic outlook on technological trends, regulatory factors, and market growth in transdermal drug delivery systems.

The Antiviral & Antimicrobial Coatings Global Market Report 2025 – By Type (Antimicrobial Coatings, Antiviral Coatings), By Material (Silver, Organic Materials, Copper, Aluminum, Silicon Dioxide), By Form (Liquid, Powder...

Antiviral Combination Therapy Global Market Report 2025 – By Type (Branded, Generic), By Drug Combination (Nucleotide Reverse Transcriptase Inhibitors/Non-Nucleotide Reverse Transcriptase Inhibitors, Integrase Inhibitor/...

Breast Cancer Drugs Global Market Report 2025 – By Type (Metastatic Breast Cancer, Triple Negative Breast Cancer, Others (Ductal Carcinoma Insitu, Invasive Ductal Carcinoma, Inflammatory Breast Cancer, Breast Cancer Duri...

Lung Cancer Drugs Global Market Report 2025 – By Drugs (Gemzar, Paraplatin, Taxotere, Navelbine, Avastin, Tarceva, Iressa, Other Drugs), By Disease Type (Small cell lung cancer (SCLC), Non-small cell lung cancer (NSCLC))...

Drugs For Hormonal Replacement Therapy Global Market Report 2025 – By Therapy Type (Estrogen Replacement Therapy, Human Growth Hormone (HGH) Replacement Therapy, Thyroid Replacement Therapy, Testosterone Replacement Ther...

Bladder Cancer Drugs Global Market Report 2025 – By Type (Non-Muscle-Invasive Bladder Cancer, Muscle-Invasive Bladder Cancer), By Application (Low-Grade Tumors, High-Grade Tumors), By Distribution Channel (Hospital Pharm...

Blood Cancer Drugs Global Market Report 2025 – By Blood Cancer Type (Leukemia, Lymphoma), By Drugs (Rituxan/Mabthera (Rituximab), Gleevec/Glivec (Imatinib), Revlimid (Lenalidomide), Velcade (Bortezomib), Tasigna (Nilotin...

Frequently Asked Questions

What is the definition of the Specific Antiviral Drugs For COVID 19 market?

How will the Specific Antiviral Drugs For COVID 19 market drivers and restraints affect the market dynamics? What forces will shape the Specific Antiviral Drugs For COVID 19 industry going forward?

The Specific Antiviral Drugs For COVID 19 market major growth driver - Rise In COVID-19 Cases The Growth Of The Market Due To Increasing Demand For Antiviral Treatments. For further insights on the Specific Antiviral Drugs For COVID 19 market, request a sample here

What is the forecast market size or the forecast market value of the Specific Antiviral Drugs For COVID 19 market?

The Specific Antiviral Drugs For COVID 19 market size has grown strongly in recent years. The specific antiviral drugs for covid 19 market size has grown rapidly in recent years. It will grow from $13 billion in 2024 to $15.23 billion in 2025 at a compound annual growth rate (CAGR) of 17.1%. The growth in the historic period can be attributed to rising hospitalization due to severe cases, increasing government funding for antiviral research, increasing demand for targeted therapeutics over generic treatments, rising awareness about early antiviral intervention, and increasing collaborations among pharmaceutical companies. The specific antiviral drugs for covid 19 market size is expected to see rapid growth in the next few years. It will grow to $28.43 billion in 2029 at a compound annual growth rate (CAGR) of 16.9%. The growth in the forecast period can be attributed to increasing focus on pandemic preparedness, increasing number of clinical trials, growing demand for effective COVID-19 treatment options, increasing prevalence of COVID-19 variants, and growing acceptance of oral antiviral therapies. Major trends in the forecast period include innovation in broad-spectrum antiviral formulations, integration of artificial intelligence in drug discovery, advancement in personalized antiviral therapies, innovation in combination therapy approaches, and integration of genomic data to target viral mutations. For further insights on the Specific Antiviral Drugs For COVID 19 market, request a sample here

How is the Specific Antiviral Drugs For COVID 19 market segmented?

The specific antiviral drugs for covid 19 market covered in this report is segmented –
1) By Type: Tablet, Injection
2) By Indication: Hospitalized Patients, Non-Hospitalized Patients, Preventive Treatment
3) By Drug Class: Nucleoside Analogues, Protease Inhibitors, Ribonucleic Acid Polymerase Inhibitors, Entry Inhibitors, Monoclonal Antibodies
4) By Route Of Administration: Oral, Intravenous, Subcutaneous, Inhalation
5) By Distribution Channel: Hospital Pharmacies, Retail Pharmacies, Other Distribution Channels Subsegments
1) By Tablet: Oral Antiviral Tablets, Combination Antiviral Tablets, Extended-Release Tablets
2) By Injection: Intravenous (IV) Antiviral Injections, Intramuscular (IM) Antiviral Injections, Subcutaneous Antiviral Injections For further insights on the Specific Antiviral Drugs For COVID 19 market, request a sample here

Which region has the largest share of the Specific Antiviral Drugs For COVID 19 market? What are the other regions covered in the report?

Who are the major players in the Specific Antiviral Drugs For COVID 19 market?

What are the key trends in the Specific Antiviral Drugs For COVID 19 market?

Major trends in the Specific Antiviral Drugs For COVID 19 market include Oral Antiviral Innovations Enhance COVID-19 Treatment Accessibility And Effectiveness. For further insights on the Specific Antiviral Drugs For COVID 19 market, request a sample here.